5247422023-04-012023-09-305247422023-09-305247422023-04-012023-09-30RelatedPartyTransactionDomain15247422023-03-31RelatedPartyTransactionDomain15247422023-09-30RelatedPartyTransactionDomain15247422023-04-012023-09-30RelatedPartyTransactionDomain25247422023-03-31RelatedPartyTransactionDomain25247422023-09-30RelatedPartyTransactionDomain25247422023-04-012023-09-30RelatedPartyTransactionDomain35247422023-03-31RelatedPartyTransactionDomain35247422023-09-30RelatedPartyTransactionDomain35247422023-04-012023-09-30RelatedPartyTransactionDomain45247422023-03-31RelatedPartyTransactionDomain45247422023-09-30RelatedPartyTransactionDomain45247422023-04-012023-09-30RelatedPartyTransactionDomain55247422023-03-31RelatedPartyTransactionDomain55247422023-09-30RelatedPartyTransactionDomain55247422023-04-012023-09-30RelatedPartyTransactionDomain65247422023-03-31RelatedPartyTransactionDomain65247422023-09-30RelatedPartyTransactionDomain65247422023-04-012023-09-30RelatedPartyTransactionDomain75247422023-03-31RelatedPartyTransactionDomain75247422023-09-30RelatedPartyTransactionDomain75247422023-04-012023-09-30RelatedPartyTransactionDomain85247422023-03-31RelatedPartyTransactionDomain85247422023-09-30RelatedPartyTransactionDomain85247422023-04-012023-09-30RelatedPartyTransactionDomain95247422023-03-31RelatedPartyTransactionDomain95247422023-09-30RelatedPartyTransactionDomain95247422023-04-012023-09-30RelatedPartyTransactionDomain105247422023-03-31RelatedPartyTransactionDomain105247422023-09-30RelatedPartyTransactionDomain105247422023-04-012023-09-30RelatedPartyTransactionDomain115247422023-03-31RelatedPartyTransactionDomain115247422023-09-30RelatedPartyTransactionDomain115247422023-04-012023-09-30RelatedPartyTransactionDomain125247422023-03-31RelatedPartyTransactionDomain125247422023-09-30RelatedPartyTransactionDomain125247422023-04-012023-09-30RelatedPartyTransactionDomain135247422023-03-31RelatedPartyTransactionDomain135247422023-09-30RelatedPartyTransactionDomain135247422023-04-012023-09-30RelatedPartyTransactionDomain145247422023-03-31RelatedPartyTransactionDomain145247422023-09-30RelatedPartyTransactionDomain145247422023-04-012023-09-30RelatedPartyTransactionDomain155247422023-03-31RelatedPartyTransactionDomain155247422023-09-30RelatedPartyTransactionDomain155247422023-04-012023-09-30RelatedPartyTransactionDomain165247422023-03-31RelatedPartyTransactionDomain165247422023-09-30RelatedPartyTransactionDomain165247422023-04-012023-09-30RelatedPartyTransactionDomain175247422023-03-31RelatedPartyTransactionDomain175247422023-09-30RelatedPartyTransactionDomain175247422023-04-012023-09-30RelatedPartyTransactionDomain185247422023-03-31RelatedPartyTransactionDomain185247422023-09-30RelatedPartyTransactionDomain185247422023-04-012023-09-30RelatedPartyTransactionDomain195247422023-03-31RelatedPartyTransactionDomain195247422023-09-30RelatedPartyTransactionDomain195247422023-04-012023-09-30RelatedPartyTransactionDomain205247422023-03-31RelatedPartyTransactionDomain205247422023-09-30RelatedPartyTransactionDomain205247422023-04-012023-09-30RelatedPartyTransactionDomain215247422023-03-31RelatedPartyTransactionDomain215247422023-09-30RelatedPartyTransactionDomain215247422023-04-012023-09-30RelatedPartyTransactionDomain225247422023-03-31RelatedPartyTransactionDomain225247422023-09-30RelatedPartyTransactionDomain225247422023-04-012023-09-30RelatedPartyTransactionDomain235247422023-03-31RelatedPartyTransactionDomain235247422023-09-30RelatedPartyTransactionDomain235247422023-04-012023-09-30RelatedPartyTransactionDomain245247422023-03-31RelatedPartyTransactionDomain245247422023-09-30RelatedPartyTransactionDomain245247422023-04-012023-09-30RelatedPartyTransactionDomain255247422023-03-31RelatedPartyTransactionDomain255247422023-09-30RelatedPartyTransactionDomain255247422023-04-012023-09-30RelatedPartyTransactionDomain265247422023-03-31RelatedPartyTransactionDomain265247422023-09-30RelatedPartyTransactionDomain265247422023-04-012023-09-30RelatedPartyTransactionDomain275247422023-03-31RelatedPartyTransactionDomain275247422023-09-30RelatedPartyTransactionDomain275247422023-04-012023-09-30RelatedPartyTransactionDomain285247422023-03-31RelatedPartyTransactionDomain285247422023-09-30RelatedPartyTransactionDomain285247422023-04-012023-09-30RelatedPartyTransactionDomain295247422023-03-31RelatedPartyTransactionDomain295247422023-09-30RelatedPartyTransactionDomain295247422023-04-012023-09-30RelatedPartyTransactionDomain305247422023-03-31RelatedPartyTransactionDomain305247422023-09-30RelatedPartyTransactionDomain305247422023-04-012023-09-30RelatedPartyTransactionDomain315247422023-03-31RelatedPartyTransactionDomain315247422023-09-30RelatedPartyTransactionDomain315247422023-04-012023-09-30RelatedPartyTransactionDomain325247422023-03-31RelatedPartyTransactionDomain325247422023-09-30RelatedPartyTransactionDomain325247422023-04-012023-09-30RelatedPartyTransactionDomain335247422023-03-31RelatedPartyTransactionDomain335247422023-09-30RelatedPartyTransactionDomain335247422023-04-012023-09-30RelatedPartyTransactionDomain345247422023-03-31RelatedPartyTransactionDomain345247422023-09-30RelatedPartyTransactionDomain345247422023-04-012023-09-30RelatedPartyTransactionDomain355247422023-03-31RelatedPartyTransactionDomain355247422023-09-30RelatedPartyTransactionDomain355247422023-04-012023-09-30RelatedPartyTransactionDomain365247422023-03-31RelatedPartyTransactionDomain365247422023-09-30RelatedPartyTransactionDomain365247422023-04-012023-09-30RelatedPartyTransactionDomain375247422023-03-31RelatedPartyTransactionDomain375247422023-09-30RelatedPartyTransactionDomain375247422023-04-012023-09-30RelatedPartyTransactionDomain385247422023-03-31RelatedPartyTransactionDomain385247422023-09-30RelatedPartyTransactionDomain385247422023-04-012023-09-30RelatedPartyTransactionDomain395247422023-03-31RelatedPartyTransactionDomain395247422023-09-30RelatedPartyTransactionDomain395247422023-04-012023-09-30RelatedPartyTransactionDomain405247422023-03-31RelatedPartyTransactionDomain405247422023-09-30RelatedPartyTransactionDomain405247422023-04-012023-09-30RelatedPartyTransactionDomain415247422023-03-31RelatedPartyTransactionDomain415247422023-09-30RelatedPartyTransactionDomain415247422023-04-012023-09-30RelatedPartyTransactionDomain425247422023-03-31RelatedPartyTransactionDomain425247422023-09-30RelatedPartyTransactionDomain425247422023-04-012023-09-30RelatedPartyTransactionDomain435247422023-03-31RelatedPartyTransactionDomain435247422023-09-30RelatedPartyTransactionDomain435247422023-04-012023-09-30RelatedPartyTransactionDomain445247422023-03-31RelatedPartyTransactionDomain445247422023-09-30RelatedPartyTransactionDomain445247422023-04-012023-09-30RelatedPartyTransactionDomain455247422023-03-31RelatedPartyTransactionDomain455247422023-09-30RelatedPartyTransactionDomain455247422023-04-012023-09-30RelatedPartyTransactionDomain465247422023-03-31RelatedPartyTransactionDomain465247422023-09-30RelatedPartyTransactionDomain465247422023-04-012023-09-30RelatedPartyTransactionDomain475247422023-03-31RelatedPartyTransactionDomain475247422023-09-30RelatedPartyTransactionDomain475247422023-04-012023-09-30RelatedPartyTransactionDomain485247422023-03-31RelatedPartyTransactionDomain485247422023-09-30RelatedPartyTransactionDomain485247422023-04-012023-09-30RelatedPartyTransactionDomain495247422023-03-31RelatedPartyTransactionDomain495247422023-09-30RelatedPartyTransactionDomain495247422023-04-012023-09-30RelatedPartyTransactionDomain505247422023-03-31RelatedPartyTransactionDomain505247422023-09-30RelatedPartyTransactionDomain505247422023-04-012023-09-30RelatedPartyTransactionDomain515247422023-03-31RelatedPartyTransactionDomain515247422023-09-30RelatedPartyTransactionDomain515247422023-04-012023-09-30RelatedPartyTransactionDomain525247422023-03-31RelatedPartyTransactionDomain525247422023-09-30RelatedPartyTransactionDomain52iso4217:INRxbrli:pureCAPLIN POINT LABORATORIES LIMITED524742CAPLIPOINTNOTLISTED2023-04-012024-03-31First half yearly2023-04-012023-09-30CrorestruetrueNoNAfalsefalseCaplin Point Laboratories LimitedDrogueria Saimed de Honduras S.AWholly owned step down SubsidiarySale of goods or services1500000000Not Applicable214640000-18590000037700000Caplin Point Laboratories LimitedNuevos Eticos Neo Ethicals S.A - GuatemalaStep down SubsidiarySale of goods or services2500000000Not Applicable977320000273200000979900000Caplin Point Laboratories LimitedNeoethicals CIA.LTDA - EcuadorWholly owned step down SubsidiarySale of goods or services1500000000Not Applicable159850000240000000142700000Caplin Point Laboratories LimitedNeo Ethicals S.A - NicaraguaWholly owned step down SubsidiarySale of goods or services1500000000Not Applicable439320000-48400000311800000Caplin Point Laboratories LimitedAshvich Infotek Private LimitedDirector and relatives of director are interestedAny other transactionRent & Consultancy125000000Not Applicable4160000-400000-300000Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionSale of MEIS Licence50000000Not Applicable1107000000<DIV > <DIV>The Audit Commitee had approved an overall&nbsp;transaction limit of INR 5 Crs between Caplin Point Laboratories Limited (CPL) and Caplin Steriles Limited (CSL). Since the format does not allow merging of cells, there is a repetion of INR 5 Crs under the head "Value of the related party transaction as approved by the audit committee" for the transactions between CPL and CSL.</DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionCorporate Office common expenses recovery50000000Not Applicable280000000<DIV > <DIV>The Audit Commitee had approved an overall&nbsp;transaction limit of INR 5 Crs between Caplin Point Laboratories Limited (CPL) and Caplin Steriles Limited (CSL). Since the format does not allow merging of cells, there is a repetion of INR 5 Crs under the head "Value of the related party transaction as approved by the audit committee" for the transactions between CPL and CSL.</DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionRecovery of Software and Systems related Expenese50000000Not Applicable146000000<DIV > <DIV>The Audit Commitee had approved an overall&nbsp;transaction limit of INR 5 Crs between Caplin Point Laboratories Limited (CPL) and Caplin Steriles Limited (CSL). Since the format does not allow merging of cells, there is a repetion of INR 5 Crs under the head "Value of the related party transaction as approved by the audit committee" for the transactions between CPL and CSL.</DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiarySale of goods or services50000000Not Applicable60000000<DIV > <DIV>The Audit Commitee had approved an overall&nbsp;transaction limit of INR 5 Crs between Caplin Point Laboratories Limited (CPL) and Caplin Steriles Limited (CSL). Since the format does not allow merging of cells, there is a repetion of INR 5 Crs under the head "Value of the related party transaction as approved by the audit committee" for the transactions between CPL and CSL.</DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryPurchase of goods or services50000000Not Applicable201000000<DIV > <DIV> <DIV>The Audit Commitee had approved an overall&nbsp;transaction limit of INR 5 Crs between Caplin Point Laboratories Limited (CPL) and Caplin Steriles Limited (CSL). Since the format does not allow merging of cells, there is a repetion of INR 5 Crs under the head "Value of the related party transaction as approved by the audit committee" for the transactions between CPL and CSL.</DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryLoan4250000000Not Applicable58500000015600000002145000000Loan0.10510 years (5 yrs moratorium + 5 years repayment)UnsecuredCapex ProjectCaplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryInterest received95700000Not Applicable9569000000Caplin Point Laboratories LimitedDr. Sridhar GanesanManaging DirectorRemuneration0Not Applicable280000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedDr. Sridhar GanesanManaging DirectorAny other transactionEquity Shares Pursuant to employees stock option scheme0Not Applicable360000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Muralidharan DChief Financial OfficerRemuneration0Not Applicable290000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Muralidharan DChief Financial OfficerAny other transactionEquity Shares Pursuant to employees stock option scheme0Not Applicable360000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Partheeban Vivek SiddarthChief Operating OfficerRemuneration0Not Applicable90000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. Venkatram GGeneral Counsel & Company SecretaryRemuneration0Not Applicable180000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. S DeenadayalanIndependent DirectorAny other transactionSitting Fees0Not Applicable12000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedMr. D SathyanarayananIndependent DirectorAny other transactionSitting Fees0Not Applicable8000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedDr. C K GariyaliIndependent DirectorAny other transactionSitting Fees0Not Applicable8000000<DIV > <DIV></DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV>Caplin Point Laboratories LimitedDr R NagendranIndependent DirectorAny other transactionSitting Fees0Not Applicable8000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiaryAny other transactionRent received0Not Applicable155000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - NA as the counter party is Wholly owned Subsidiary of the listed entity</DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiarySale of fixed assets0Not Applicable3000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - NA as the counter party is Wholly owned Subsidiary of the listed entity</DIV> <DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiaryAny other transactionEquity Investment0Not Applicable40000000660020000700020000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - NA as the counter party is Wholly owned Subsidiary of the listed entity</DIV></DIV></DIV>Caplin Steriles LimitedMr. M SathyanarayanChief Financial OfficerRemuneration0Not Applicable330000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV> <DIV></DIV></DIV>Caplin Steriles LimitedMr. M SathyanarayanChief Financial OfficerAny other transactionEquity Shares Pursuant to employees stock option scheme0Not Applicable310000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Caplin Steriles LimitedAshvich Infotek Private LimitedDirectors and relatives of directors are interestedAny other transactionRent & Consultancy20000000Not Applicable703000000Caplin Steriles LimitedSunsole Solar Private LimitedAssociate CompanyPurchase of goods or services0Not Applicable1253000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV></DIV></DIV>Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)Ashvich Infotek Private LimitedDirectors and relatives of directors are interestedAny other transactionRent paid by COL0Not Applicable5000000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee&nbsp; - NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV></DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)Fellow subsidaryLoan0Not Applicable830600000830600000830600000Loan0.06310 (3 years moratorium and 7 years repayment)UnsecuredNew project<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV> <DIV></DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Drogueria Saimed de Honduras S.AWholly owned Subsidiary CompanySale of goods or services750000000Not Applicable129370000966100000802700000Caplin Point Far East Limited, (Hong Kong)Nuevos Eticos Neo Ethicals S.A - GuatemalaSubsidiarySale of goods or services750000000Not Applicable266860000943200000583800000Caplin Point Far East Limited, (Hong Kong)Neoethicals CIA.LTDA - EcuadorWholly owned Subsidiary CompanySale of goods or services500000000Not Applicable129240000457900000491600000Caplin Point Far East Limited, (Hong Kong)Neo Ethicals S.A - NicaraguaWholly owned Subsidiary CompanySale of goods or services600000000Not Applicable87320000409400000-41200000Caplin Point Far East Limited, (Hong Kong)Caplin Point El Salvador, S.A. De C.VWholly owned Subsidiary CompanySale of goods or services0Not Applicable0-171200000-174400000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV> <DIV>&nbsp;</DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate. </DIV></DIV></DIV>Caplin Point Far East Limited, (Hong Kong)Caplin Point Laboratories Colombia SASWholly owned Subsidiary CompanyAny other transactionEquity Investment0Not Applicable61000002740000033500000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction is between two Wholly Owned Subsidiaries</DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaCaplin Point Laboratories Colombia SASFellow subsidaryAny other transactionTrade Payables0Not Applicable024700002490000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate. </DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaDrogueria Saimed de Honduras S.AFellow subsidarySale of goods or services0Not Applicable91300002793000037420000<DIV > <DIV> <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaNeo Ethicals S.A - NicaraguaFellow subsidarySale of goods or services0Not Applicable99800003701000047450000<DIV > <DIV> <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaNeoethicals CIA.LTDA - EcuadorFellow subsidarySale of goods or services0Not Applicable01960000019670000<DIV > <DIV> <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate. </DIV></DIV></DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaDrogueria Saimed de Honduras S.AFellow subsidaryPurchase of goods or services0Not Applicable086600008690000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate. </DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaNeoethicals CIA.LTDA - EcuadorFellow subsidaryPurchase of goods or services0Not Applicable19400002044000022600000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaNeo Ethicals S.A - NicaraguaFellow subsidaryPurchase of goods or services0Not Applicable33000001141000014860000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -NA as the transaction does not cross the threshold as specified under reg 23(2b)</DIV> <DIV></DIV></DIV>Nuevos Eticos Neo Ethicals S.A - GuatemalaMr. Ashok Gorkey PartheebanBusiness Head LatamRemuneration0Not Applicable824000000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee - Not <SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA'>Applicable </SPAN></DIV></DIV></DIV>Drogueria Saimed de Honduras S.ANeo Ethicals S.A - NicaraguaFellow subsidaryPurchase of goods or services0Not Applicable0500000500000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -Not Applicable&nbsp;as the transaction is between two Wholly Owned Subsidiaries</DIV> <DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate</DIV></DIV></DIV></DIV>Neoethicals CIA.LTDA - EcuadorDrogueria Saimed de Honduras S.AFellow subsidarySale of goods or services0Not Applicable15000014300001600000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -Not Applicable&nbsp;as the transaction is between two Wholly Owned Subsidiaries</DIV> <DIV></DIV></DIV>Neo Ethicals S.A - NicaraguaCaplin Point El Salvador, S.A. De C.V.Fellow subsidaryPurchase of goods or services0Not Applicable017100001720000<DIV > <DIV>Value of Related Party Transactions as approved by the Audit Committee -Not Applicable&nbsp;as the transaction is between two Wholly Owned Subsidiaries</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate</DIV></DIV></DIV></DIV>Neo Ethicals S.A - NicaraguaDrogueria Saimed de Honduras S.AFellow subsidaryPurchase of goods or services0Not Applicable02451000024640000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -Not Applicable&nbsp;as the transaction is between two Wholly Owned Subsidiaries</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate</DIV></DIV></DIV></DIV></DIV>Neo Ethicals S.A - NicaraguaNeoethicals CIA.LTDA - EcuadorFellow subsidaryPurchase of goods or services0Not Applicable092700009320000<DIV > <DIV> <DIV>Value of Related Party Transactions as approved by the Audit Committee -Not Applicable&nbsp;as the transaction is between two Wholly Owned Subsidiaries</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>No transaction during period. The difference between opening and closing balance is due to currency exchange rate</DIV></DIV></DIV></DIV></DIV>Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionRent Received50000000Not Applicable24000000<DIV > <DIV>The Audit Commitee had approved an overall&nbsp;transaction limit of INR 5 Crs between Caplin Point Laboratories Limited (CPL) and Caplin Steriles Limited (CSL). Since the format does not allow merging of cells, there is a repetion of INR 5 Crs under the head "Value of the related party transaction as approved by the audit committee" for the transactions between CPL and CSL.</DIV></DIV>Caplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned Subsidiary CompanyAny other transactionInterest Received0Not Applicable1360000000<DIV > <DIV>NA as the transaction is between two Wholly -&nbsp;Owned Subsidiaries</DIV></DIV>